References
- Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Rev. 4th ed. Lyon, France: IARC; 2017.
- Pina-Oviedo S, Miranda RN, Medeiros LJ. Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder. Am J Surg Pathol. 2018;42(1):116–129. doi:10.1097/PAS.0000000000000954.
- Natkunam Y, Gratzinger D, Chadburn A, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018;132(18):1871–1878. doi:10.1182/blood-2018-04-842559.
- Shahid S, Rossi C, Vyas P, Bollard C, Dave H. Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2019;36(5):309–316. doi:10.1080/08880018.2019.1637982.
- Menter T, Schlageter M, Bastian L, Haberthür R, Rätz Bravo AE, Tzankov A. Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia. Hematol Oncol. 2014;32(1):47–51. doi:10.1002/hon.2054.
- Abruzzo LV, Rosales CM, Medeiros LJ, et al. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. Am J Surg Pathol. 2002;26(5):630–636. doi:10.1097/00000478-200205000-00009.
- Bhargava R, Barbashina V, Filippa DA, Teruya-Feldstein J. Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with cladribine for hairy cell leukemia. Leuk Lymphoma. 2004;45(5):1043–1048. doi:10.1080/10428190310001625890.
- Sung L, Dix D, Allen U, Weitzman S, Cutz E, Malkin D. Epstein-Barr virus-associated lymphoproliferative disorder in a child undergoing therapy for localized rhabdomyosarcoma. Med Pediatr Oncol. 2000;34(5):358–360. doi:10.1002/(SICI)1096-911X(200005)34:5<358::AID-MPO9>3.0.CO;2-K.
- Nakashima K, Kodama Y, Nishikawa T, et al. Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma. Pediatr Int. 2016;58(5):388–390. doi:10.1111/ped.12812.
- Blatt J, LaQuaglia M, Hunt JP, Morris DE, Kasow KA. Non-Hodgkin lymphoma in a child with neuroblastoma preceding autologous stem cell transplant. Clin Lymphoma Myeloma Leuk. 2012;12(3):213–215. doi:10.1016/j.clml.2012.01.013.
- Bethge N, Honne H, Andresen K, et al. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma. PLoS One. 2014;9(9):e104249doi:10.1371/journal.pone.0104249.
- Powell JL, Bunin NJ, Callahan C, et al. An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma. Bone Marrow Transplant. 2004;33(6):651–657. doi:10.1038/sj.bmt.1704402.
- Heath JA, Broxson EH, Dole MG, et al. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue. J Pediatr Hematol Oncol. 2002;24(2):160–163.
- Lones MA, Kirov I, Said JW, Shintaku IP, Neudorf S. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant. 2000;26(9):1021–1024. doi:10.1038/sj.bmt.1702593.
- Crombie JL, Lacasce AS. Epstein Barr virus associated B-cell lymphomas and iatrogenic lymphoproliferative disorders. Front Oncol. 2019;9:109doi:10.3389/fonc.2019.00109.